found that after tumor patients were treated with PD-1 inhibitors proliferation of Memory T-cell which can express CD69 and CD103 and increased numbers of CD8 + T-cells in tumor tissue were associated with improved patient survival (58). The gene discussed is CD8A; the disease is neoplasm.